Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience

Overview

Journal Nephrourol Mon

Publisher Brieflands

Specialty Nephrology

Date 2013 Dec 19

PMID 24350088

Citations 9

Authors

Rizna Abdul Cader

Halim Abdul Gafor

Rozita Mohd

Wei Yen Kong

Norazimah Arshad

Norella Kong

Affiliations

Soon will be listed here.

Abstract

Background: Coupled plasma filtration adsorption (CPFA) is a novel extracorporeal blood purification therapy for sepsis which adsorbs both proinflammatory and anti-inflammatory mediators from filtered plasma, thereby achieving early haemodynamic stability and a reduction in inotropic support requirement.

Objectives: The main objective was to review our centers' experience with CPFA in septic patients.

Patients And Methods: A retrospective chart review of all septic patients who received CPFA was performed. All patients were initially treated according to the 'surviving sepsis care bundle' with fluid resuscitation, antibiotics, and inotropes as required. CPFA was started as soon as possible after a nephrologists' assessment.

Results: Twenty five patients with sepsis received CPFA (15 M, 10 F, mean age 49.60 ± 18.97 years). Comorbidities included hypertension (n = 10, 40%), diabetes mellitus (n = 6, 24%), ischemic heart disease (n = 6, 24%), and an immunosuppressed state (n = 10, 40%). All patients received one cycle of CPFA with median duration of 5 (1-10) hours. CPFA was well tolerated but we encountered technical problems, especially filter clotting as CPFA was performed heparin free. 14 (56%) patients died within 28 days of treatment. CRP correlated with PCT (P = 0.040) and had an inverse trend with albumin (P = 0.066). Serum albumin was a strong predictor of mortality.

Conclusions: The high prevalence of fungaemia and mortality could be attributed to many patients on chronic immunosuppressive therapy. Nonetheless, CPFA albeit expensive, does add to our armamentarium of extracorporeal treatment for severe sepsis. Regional citrate anticoagulation with CPFA may overcome problems with filter clotting.

Citing Articles

[Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems].

Grafe C, Weidhase L, Liebchen U, Weigand M, Scharf C Anaesthesiologie. 2023; 72(12):843-851.

PMID: 37707564 DOI: 10.1007/s00101-023-01341-w.

Blood purification for sepsis: an overview.

Zhang L, Feng Y, Fu P Precis Clin Med. 2022; 4(1):45-55.

PMID: 35693122 PMC: 8982546. DOI: 10.1093/pcmedi/pbab005.

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?.

Constantinescu C, Pasca S, Tat T, Teodorescu P, Vlad C, Iluta S J Immunother Cancer. 2020; 8(1).

PMID: 32474415 PMC: 7264828. DOI: 10.1136/jitc-2020-000742.

Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.

Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C Crit Care. 2018; 22(1):262.

PMID: 30360755 PMC: 6202855. DOI: 10.1186/s13054-018-2181-z.

Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome.

Tuerdi B, Zuo L, Sun H, Wang K, Wang Z, Li G Braz J Med Biol Res. 2017; 51(1):e6378.

PMID: 29185591 PMC: 5685057. DOI: 10.1590/1414-431X20176378.

References

Bellomo R, Ronco C . Renal replacement therapy in the intensive care unit. Crit Care Resusc. 2006; 1(1):13-24. View

Prieto M, Kilstein J, Bagilet D, Pezzotto S . [C-reactive protein as a marker of mortality in intensive care unit]. Med Intensiva. 2008; 32(9):424-30. DOI: 10.1016/s0210-5691(08)75719-x. View

Lentini P, Cruz D, Nalesso F, De Cal M, Bobek I, Garzotto F . [A pilot study comparing pulse high volume hemofiltration (pHVHF) and coupled plasma filtration adsorption (CPFA) in septic shock patients]. G Ital Nefrol. 2009; 26(6):695-703. View

Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M . Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med. 2003; 29(5):703-8. DOI: 10.1007/s00134-003-1724-0. View

Tetta C, Gianotti L, Cavaillon J, Wratten M, Fini M, Braga M . Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med. 2000; 28(5):1526-33. DOI: 10.1097/00003246-200005000-00045. View

Hu D, Sun S, Zhu B, Mei Z, Wang L, Zhu S . Effects of coupled plasma filtration adsorption on septic patients with multiple organ dysfunction syndrome. Ren Fail. 2012; 34(7):834-9. DOI: 10.3109/0886022X.2012.684553. View

Dellinger R, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J . Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30(4):536-55. DOI: 10.1007/s00134-004-2210-z. View

Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A . A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002; 30(6):1250-5. DOI: 10.1097/00003246-200206000-00015. View

Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P . High-volume haemofiltration in human septic shock. Intensive Care Med. 2001; 27(6):978-86. DOI: 10.1007/s001340100963. View

10.

Chernoff A, Granowitz E, Shapiro L, Vannier E, Lonnemann G, Angel J . A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 1995; 154(10):5492-9. View

11.

Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P . Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989; 17(10):975-8. DOI: 10.1097/00003246-198910000-00001. View

12.

Goldwasser P, Feldman J . Association of serum albumin and mortality risk. J Clin Epidemiol. 1997; 50(6):693-703. DOI: 10.1016/s0895-4356(97)00015-2. View

13.

Formica M, Inguaggiato P, Bainotti S, Wratten M . Coupled plasma filtration adsorption. Contrib Nephrol. 2007; 156:405-10. DOI: 10.1159/000102131. View

14.

Bellomo R, Tipping P, Boyce N . Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993; 21(4):522-6. DOI: 10.1097/00003246-199304000-00011. View

15.

Meier-Kriesche H, Finkel K, Gitomer J, Dubose Jr T . Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis. 1999; 33(4):e8. DOI: 10.1016/s0272-6386(99)70249-0. View

16.

Hesselvik J, Blomback M, Brodin B, Maller R . Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med. 1989; 17(8):724-33. DOI: 10.1097/00003246-198908000-00002. View

17.

Sykora R, Chvojka J, Krouzecky A, Radej J, Kuncova J, Varnerova V . Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock. Shock. 2008; 31(5):473-80. DOI: 10.1097/SHK.0b013e318188dec5. View

18.

Mao H, Yu S, Yu X, Zhang B, Zhang L, Xu X . Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome. Int J Artif Organs. 2009; 32(1):31-8. DOI: 10.1177/039139880903200104. View

19.

Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A . Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003; 31(6):1737-41. DOI: 10.1097/01.CCM.0000063440.19188.ED. View

20.

Pinnick R, Wiegmann T, DIEDERICH D . Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med. 1983; 308(5):258-61. DOI: 10.1056/NEJM198302033080506. View